Cataya is a synthetic biology company focused on biomanufacturing chemical and biochemical products. Its pipeline targets high-value ingredient molecules with applications across food, cosmetics, and general consumer goods. Founded in 2021, the company is led by industry veterans and CEO Dr. Lishan Zhao. Cataya has completed three financing rounds within a single year, reflecting rapid development and market potential. Proceeds from the recent round will fund pipeline R&D, talent recruitment, and construction of manufacturing facilities. The company plans to establish research and business units in the US and Japan in the future. Eight Roads noted support will come from both their technology and healthcare teams to back Cataya’s product-driven R&D platforms.

Total raised

$14M

Funding rounds

1

Latest round

Series A

Latest activity

Oct 2023